C4Diagnostics is a biotech company specialized in the development of in vitro diagnostic (IVD) tests for human infectious diseases and has a strategy for the better management of Human infectious diseases by developing game changing IVD tests which are significantly faster than standard methods while maintaining comparable or better performance. Its pipeline of products currently focuses on the diagnosis of Covid-19 (C4Covid-19), Legionnaires’ Disease (C4Legio-LFA), urinary tract infections (C4UTI) and the development of antimicrobial susceptibility tests (C4AST). C4Diagnostics also has a business unit dedicated to environmental diagnostics, called C4Services. It provides services for the detection of SARS-CoV-2 in the environment (wastewater, air, surface) and has contributed to several Covid-19 surveillance and prevention campaigns since the beginning of the pandemic.
